Acquisition/Asset Disposal - Form 8-K

On April 9, 2024, in connection with the Acquisition (as defined below), Nuvation Bio Inc. (the "Company") entered into the amended and restated warrant agreement (the "Warrant Agreement") with Continental Stock Transfer & Trust Company, as warrant agent, pursuant to which the Company issued the Consideration Warrants (as defined below) in registered form. The information contained in Item 1.01 of the Company's Current Report on Form 8-K filedwith the Securities and Exchange Commission (the "SEC") on March 25, 2024 (the "March 25, 2024 Current Report") is incorporated by reference into this Item 1.01.

The foregoing description of the Warrant Agreement does not purport to be complete and is qualified in its entirety by reference to the Warrant Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-Kand is incorporated herein by reference.